Gladys I. Rodriguez

Oncology

4383 Medical Dr
San Antonio, TX 78229

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3 publications

TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.

TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.

Journal: Breast cancer research and treatment

Published: May 02, 2017

Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.

Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.

Journal: SpringerPlus

Published: April 24, 2014

Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage.

Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage.

Journal: Journal of oncology practice

Published: January 21, 2014

Showing 1-3 of 3

Last Updated: 09/26/2026